These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2866493)

  • 41. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
    Strand M; Hetta J; Rosen A; Sörensen S; Malmström R; Fabian C; Marits K; Vetterskog K; Liljestrand AG; Hegen C
    J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.
    Lapierre YD; Tremblay A; Gagnon A; Monpremier P; Berliss H; Oyewumi LK
    J Clin Psychiatry; 1982 Sep; 43(9):372-4. PubMed ID: 6126475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug interactions in controlled clinical trials.
    Gershon S
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):95-9. PubMed ID: 6130080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind comparison of clobazam and diazepam in the treatment of anxiety neurosis.
    Mendels J; Secunda S; Schless A; Sandler K; Singer J
    J Clin Pharmacol; 1978 Jul; 18(7):353-7. PubMed ID: 27538
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of the therapeutic effect, tolerance and safety of ketazolam and diazepam administered for six months to out-patients with chronic anxiety neurosis.
    Fabre LF; McLendon DM; Stephens AG
    J Int Med Res; 1981; 9(3):191-8. PubMed ID: 6113174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Etizolam in the treatment of generalized anxiety disorder: a controlled clinical trial.
    Bertolino A; Mastucci E; Porro V; Corfiati L; Palermo M; Ecari U; Ceccarelli G
    J Int Med Res; 1989; 17(5):455-60. PubMed ID: 2572494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled comparison of the effects and abrupt discontinuation of buspirone and lorazepam.
    Bourin M; Malinge M
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):567-75. PubMed ID: 8588056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clobazam versus diazepam--a double-blind study in anxiety neurosis.
    Doongaji DR; Sheth A; Apte JS; Lakdawala PD; Khare CB; Thatte SS
    J Clin Pharmacol; 1978 Jul; 18(7):358-64. PubMed ID: 27539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind comparative study of desipramine hydrochloride and diazepam in the control of mixed anxiety/depression symptomatology.
    Kleber RJ
    J Clin Psychiatry; 1979 Apr; 40(4):165-70. PubMed ID: 370109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.
    Lader M; Scotto JC
    Psychopharmacology (Berl); 1998 Oct; 139(4):402-6. PubMed ID: 9809861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW; Daniel JT; King RE; Moore DT
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A controlled clinical trial of alprazolam for the treatment of anxiety.
    Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
    Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder.
    Boyer WF; Feighner JP
    Int Clin Psychopharmacol; 1993; 8(3):173-6. PubMed ID: 7903326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function.
    Lucki I; Rickels K; Giesecke MA; Geller A
    Br J Clin Pharmacol; 1987 Feb; 23(2):207-11. PubMed ID: 2881573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.
    Rickels K; Downing R; Schweizer E; Hassman H
    Arch Gen Psychiatry; 1993 Nov; 50(11):884-95. PubMed ID: 8215814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The side effect profile of buspirone in comparison to active controls and placebo.
    Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
    Petracca A; Nisita C; McNair D; Melis G; Guerani G; Cassano GB
    J Clin Psychiatry; 1990 Sep; 51 Suppl():31-9. PubMed ID: 2211564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.